Clinical Trial Update: Epidemiology and Immunology of Hemophilia A Inhibitors

View source ↗

Summary

This completed NHLBI-sponsored clinical trial update investigates the epidemiology and immunology of inhibitors in Hemophilia A.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Blood Disease, Hemophilia A | Status: COMPLETED